HELSON, Lawrence,SHOPP, George, M.,BOUCHARD, Annie,MAJEED, Muhammed
申请号：
EP17861307
公开号：
EP3528848A4
申请日:
2017.10.19
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention includes compositions and methods for preventing one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by an active agent or a drug in a human or animal subject comprising: an amount of a phosphatidylglycerol adapted for oral administration effective to reduce or prevent one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by the active agent or drug, and one or more organoleptic, thixotropic, or both organoleptic and thixotropic agents.
